GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 92 filers reported holding GERON CORP in Q2 2013. The put-call ratio across all filers is 59.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,489,795 | -34.0% | 3,061,224 | 0.0% | 0.04% | -35.1% |
| Q2 2023 | $9,826,529 | +47.9% | 3,061,224 | 0.0% | 0.06% | +58.3% |
| Q1 2023 | $6,642,856 | +407.5% | 3,061,224 | +660.3% | 0.04% | +176.9% |
| Q4 2014 | $1,309,000 | +62.6% | 402,629 | 0.0% | 0.01% | +30.0% |
| Q3 2014 | $805,000 | -37.7% | 402,629 | 0.0% | 0.01% | -37.5% |
| Q2 2014 | $1,292,000 | +54.4% | 402,629 | 0.0% | 0.02% | +45.5% |
| Q1 2014 | $837,000 | -56.1% | 402,629 | 0.0% | 0.01% | -59.3% |
| Q4 2013 | $1,908,000 | -43.0% | 402,629 | -59.7% | 0.03% | -43.8% |
| Q3 2013 | $3,350,000 | +123.3% | 1,000,000 | 0.0% | 0.05% | +60.0% |
| Q2 2013 | $1,500,000 | – | 1,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 5,732,770 | $7,854,000 | 1.22% |
| RA Capital Management | 30,126,299 | $41,273,000 | 0.57% |
| NEA Management Company, LLC | 13,461,538 | $18,442,000 | 0.22% |
| Virtus ETF Advisers LLC | 146,618 | $201,000 | 0.09% |
| Forefront Analytics, LLC | 82,336 | $113,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 226,098 | $310,000 | 0.03% |
| Summit X, LLC | 84,077 | $114,000 | 0.03% |
| Poehling Capital Management, INC. | 53,000 | $73,000 | 0.02% |
| Arnhold LLC | 154,700 | $212,000 | 0.02% |
| Piscataqua Savings Bank | 12,500 | $17,000 | 0.02% |